483
SUNNY PHARMTECH INC.SUNNY PHARMTECH INC. – FDA 483, Nov 4, 2022
Record Details
An FDA inspection of SUNNY PHARMTECH INC in Taoyuan City, Taiwan, a drug and API manufacturer, revealed significant deficiencies in quality control. The firm failed to establish procedures to prevent objectionable microorganisms, maintain and clean equipment adequately, and ensure proper batch production and equipment maintenance records. These issues indicate a lack of robust quality systems, posing potential risks to drug product safety and quality.
View Company Profile
ID · c6e16d6c-7323-4534-8de0-fe2ada81b691
Other documents for SUNNY PHARMTECH INC.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.